文献速递产科母胎医学

心肌病女性的母亲妊娠结局:系统综述与Meta分析

Maternal pregnancy outcomes in women with cardiomyopathy: a systematic review and meta-analysis.
PubMed 文献 · Am J Obstet Gynecol · 2022-05-21

该系统综述与Meta分析检索截至2022年4月24日的多个数据库,纳入14项观察性研究(n=57,539,306次妊娠),发现心肌病孕妇的剖宫产、严重母亲不良心血管事件及院内死亡风险均高于无心脏病孕妇和非心肌病心脏病孕妇,作者强调孕前风险评估和多学科团队管理。

要点

  • 心肌病孕妇剖宫产风险高于无心脏病者(OR 2.96)和非心肌病心脏病者(OR 1.90)。
  • 心肌病孕妇严重母亲不良心血管事件风险高于无心脏病者(OR 206.64)和非心肌病心脏病者(OR 7.09)。
  • 心肌病孕妇院内死亡风险高于无心脏病者(OR 126.67)和非心肌病心脏病者(OR 4.30)。

核心结论

  • 与无心脏病孕妇和非心肌病心脏病孕妇相比,心肌病孕妇的母亲不良结局(包括母亲死亡)风险增加。
  • 作者认为结果凸显孕前风险评估的重要性,以便在妊娠前做出知情决策。
  • 作者认为受心肌病影响的妊娠属高危,应由产科和心脏科专家多学科团队管理。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Ovid Embase、Ovid MEDLINE、Cochrane Library和ClinicalTrials.gov,自建库至2022年4月24日。
  • 纳入报告心肌病(任何亚型)孕妇与对照人群预设母亲结局的观察性队列、病例对照和病例队列研究。
  • 共纳入14项研究,n=57,539,306次妊娠;两名评价者独立评估纳入资格和偏倚风险,分歧由第三名评价者解决。

主要发现

  • 心肌病孕妇剖宫产率高于无心脏病孕妇(OR 2.96,95%CI 2.47-3.55;I²=95%;P≤.00001)。
  • 心肌病孕妇剖宫产率高于非心肌病心脏病孕妇(OR 1.90,95%CI 1.62-2.22;I²=91%;P<.00001)。
  • 心肌病孕妇严重母亲不良心血管事件风险高于无心脏病孕妇(OR 206.64,95%CI 192.09-222.28;I²=73%;P<.0001)。
  • 心肌病孕妇严重母亲不良心血管事件风险高于非心肌病心脏病孕妇(OR 7.09,95%CI 6.08-8.27;I²=88%;P<.00001)。
  • 心肌病孕妇院内死亡率高于无心脏病孕妇(OR 126.67,95%CI 43.01-373.07;I²=87%;P<.00001)和非心肌病心脏病孕妇(OR 4.30,95%CI 3.42-5.40;I²=0%;P<.00001)。

临床怎么用

  • 作者认为心肌病孕妇的母亲不良结局风险增加,应进行孕前风险评估以支持知情决策。
  • 作者认为受心肌病影响的妊娠属高危,应由产科和心脏科专家多学科团队管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study aimed to systematically assess the impact of cardiomyopathy on maternal pregnancy outcomes. DATA SOURCES: PubMed, Ovid Embase, Ovid MEDLINE, Cochrane Library, and ClinicalTrials.gov were systematically searched from inception to April 24, 2022. STUDY ELIGIBILITY CRITERIA: Observational cohort, case-control, and case-cohort studies in human populations were included if they reported predefined maternal outcomes for pregnant women with cardiomyopathy (any subtype) and for an appropriate control population (pregnant women with no known heart disease or pregnant women with noncardiomyopathy heart disease). METHODS: Two reviewers independently assessed the articles for eligibility and risk of bias, and conflicts were resolved by a third reviewer. Data were extracted and synthesized according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Meta-Analyses of Observational Studies in Epidemiology guidelines. RESULTS: A total of 14 studies (n=57,539,306 pregnancies) were eligible for inclusion. Women with cardiomyopathy were more likely to deliver by cesarean delivery than women with no heart disease (odds ratio, 2.96; 95% confidence interval, 2.47-3.55; I2=95%; P≤.00001) or women with noncardiomyopathy heart disease (odds ratio, 1.90; 95% confidence interval, 1.62-2.22; I2=91%; P<.00001). Having cardiomyopathy conferred a greater risk for experiencing severe maternal adverse cardiovascular events during pregnancy when compared with not having any heart disease (odds ratio, 206.64; 95% confidence interval, 192.09-222.28; I2=73%; P<.0001) or having noncardiomyopathy heart disease (odds ratio, 7.09; 95% confidence interval; 6.08-8.27; I2=88%; P<.00001). In-hospital mortality was significantly higher among women with cardiomyopathy than among women with no heart disease (odds ratio, 126.67; 95% confidence interval, 43.01-373.07; I2=87%; P<.00001) or among women with noncardiomyopathy heart disease (odds ratio, 4.30; 95% confidence interval, 3.42-5.40; I2=0%; P<.00001). CONCLUSION: Pregnant women with cardiomyopathy have increased risks for adverse maternal outcomes, including maternal death, when compared with both women with no heart disease and women with noncardiomyopathy heart disease. Our results highlight the importance of preconception risk assessments to allow for informed decision-making before pregnancy. Pregnancies affected by cardiomyopathy are high risk and should be managed by expert, multidisciplinary obstetrical and cardiology teams.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Eggleton EJ, McMurrugh KJ, Aiken CE, et al. Maternal pregnancy outcomes in women with cardiomyopathy: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022. PMID: 35609641. doi:10.1016/j.ajog.2022.05.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。